NIH Director Jay Bhattacharya will add another job to his plate: acting CDC director, an administration official not authorized to speak publicly confirmed to STAT’s Chelsea Cirruzzo and Anil Oza.
Fziomed's dual-polymer adhesion barrier technology platform is becoming a new standard of care as an adjunctive therapy.